This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Report of Three Cases

SAMUEL DE LA PAVA, M.D.; GORYUN NIGOGOSYAN, M.D.; JOHN W. PICKREN, M.D.

Arch Intern Med. 1962;109(4):391-399.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

The modern physician looks upon serum sickness and particularly upon the fatal forms of it as something belonging to the past. In the early decade of the twentieth century the use of heterologous antisera by physicians became increasingly popular, as it was the only means of attacking infectious diseases, and it was then that serum sickness was a rather common complication. The arrival of the antibiotic era has fortunately rendered obsolete the use of this cumbersone technique for treating infections and accounts for the lack of recent reports on fatal human cases. Although papers on the subject are found in the literature, they lack detailed observations on the kidneys.^5,6 For comprehensive reviews on serum sickness the reader is referred to the papers of Rich¹ and Sherman.²

Bjorklund has stated that horse anti-human-cancer serum in vitro kills human tumor cells and does not damage normal human cells. . . . [Full Text PDF of this Article]

Author Affiliations
BUFFALO

From the Department of Pathology, Roswell Park Memorial Institute.

Footnotes
Submitted for publication Feb. 27, 1961.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?